Symbols

CLPT

ClearPoint Neuro·NASDAQ

--(--)

CLPT Profile

Clearpoint Neuro, Inc.

A global therapy-enabling platform company providing navigation and delivery to the brain

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

12/09/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

172

Fiscal Year Ends

12-31

Website

www.clearpointneuro.com

Security Type

Common stock

Office address

120 S. Sierra Ave. Suite 100 Solana Beach California 92075

Business

Introduction

ClearPoint Neuro, Inc., was incorporated in Delaware in 1998. The company is a commercial-stage medical device company that develops and sells integrated systems for minimally invasive neurosurgery in the brain. Since its inception, ClearPoint Neuro has been committed to the research and development of the basic technology of MRI-guided intervention, building an intellectual property portfolio and developing commercial applications for its technology. Its business scope has expanded from MRI equipment to operating rooms, providing neurosurgery instrument products, and providing consulting services to pharmaceutical companies. Through subsequent acquisitions, the company expanded its product portfolio into neurocritical care, adding new therapies and technologies for the treatment of cerebral hemorrhage, intraventricular hemorrhage and intracranial fluid management.